Glipizide And Metformin Hydrochloride Tablet, Film Coated
FDA Label NDC 0093-7455

40 label sections · Submitted to the FDA by Teva Pharmaceuticals Usa, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Teva Pharmaceuticals Usa, Inc. for the product Glipizide And Metformin Hydrochloride (NDC 0093-7455). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, mechanism of action, glipizide and metformin hydrochloride tablets, glipizide, metformin hydrochloride, patients with type 2 diabetes, renal impairment, hepatic impairment, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.